NAGE
Niagen Bioscience, Inc.
3.10$
+1.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.0% | 3.1% | 1.3% | -1.2% | 13.7% | 29.5% | 25.9% | 4.0% | 10.9% | 2.0% | -3.8% | 9.3% | 4.6% | |
| 2.3% | 1.8% | 1.8% | 1.6% | 1.4% | 1.2% | 1.2% | 1.1% | 1.1% | 1.1% | 1.5% | 1.6% | 1.3% | |
| 5.7% | 4.9% | 4.4% | 5.2% | 2.9% | 2.6% | 3.5% | 4.8% | 5.2% | 5.2% | 5.5% | 5.8% | 5.4% | |
| -2.2% | -4.3% | -2.9% | -8.1% | 2.0% | 17.8% | 9.0% | -13.8% | -8.8% | -10.8% | -16.3% | -1.6% | -9.5% | |
| 0.1% | 0.1% | 0.2% | 0.1% | 0.2% | 0.2% | 0.1% | 0.4% | 0.1% | 0.3% | 0.2% | 0.3% | 0.2% | |
| -0.1% | -0.1% | -0.2% | -0.1% | -0.1% | -0.2% | -0.1% | -0.4% | -0.1% | -0.3% | 16.7% | -0.3% | 3.9% | |
| – | – | – | – | – | – | 0.0% | 0.0% | – | -0.7% | -7.5% | -9.3% | – | |
| – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| 0.0% | -0.4% | -0.1% | 2.6% | 4.1% | 12.9% | 10.2% | 12.0% | 0.4% | -0.2% | -7.3% | -8.4% | -3.6% | |
| 1.9% | 2.6% | 1.1% | 1.4% | 17.6% | 42.1% | 35.9% | 15.6% | 11.2% | 1.5% | 5.6% | 0.6% | 4.9% | |
| 1.9% | 3.0% | 1.1% | -1.2% | 13.5% | 29.2% | 25.8% | 3.6% | 10.8% | 1.7% | -4.0% | 9.0% | 4.4% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.